Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2000
06/29/2000WO2000037076A1 Combinations of farnesyl transferase inhibitors and irinotecan or camptothecin for treating cancer
06/29/2000WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000WO2000037068A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/29/2000WO2000037065A2 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
06/29/2000WO2000037061A2 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
06/29/2000WO2000037059A2 Compositions and methods to inactivate n-type calcium channels
06/29/2000WO2000037035A1 Deodorizing cosmetic agents
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000037022A2 Combination therapy for the treatment of sepsis
06/29/2000WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000WO2000036918A1 Methods and compositions for treatment of cell proliferative disorders
06/29/2000WO2000024437A8 Textured and porous silicone rubber
06/29/2000WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii
06/29/2000WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000010973A3 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
06/29/2000WO2000009073A3 Blood-brain barrier therapeutics
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker
06/29/2000WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
06/29/2000WO2000001409A3 Porcine circovirus and parvovirus vaccine
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO2000000594A3 Human transferases
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE19859727A1 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung The use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related organ dysfunctions, age-related diseases for prolonging life
06/29/2000DE19858812A1 Desodorierende kosmetische Mittel Deodorizing cosmetic products
06/29/2000CA2358492A1 Combination therapy for the treatment of sepsis
06/29/2000CA2356765A1 Bone resorption inhibitors
06/29/2000CA2356624A1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
06/29/2000CA2356460A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2356010A1 Treatment of hepatitis c virus infections with interleukin-10
06/29/2000CA2355968A1 Novel protein and dna thereof
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355830A1 Crystalline form of activated trap and use thereof for structure-based drug design
06/29/2000CA2355704A1 Melatonin derivatives and medicine containing same
06/29/2000CA2355694A1 Novel bicyclic compounds
06/29/2000CA2355469A1 Dibenzo[a,g]quinolizinium derivatives and the salts thereof
06/29/2000CA2355368A1 Cgmp pde 5 inhibitors for inhalation in the treatment of sexual dysfunction
06/29/2000CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
06/29/2000CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2354779A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000CA2352326A1 Combination chemotherapy
06/29/2000CA2351674A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/29/2000CA2333626A1 Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonics
06/29/2000CA2293081A1 Restenosis drug therapy
06/28/2000EP1013764A1 Immunomodulators
06/28/2000EP1013660A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia
06/28/2000EP1013283A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013282A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013278A1 The extract of pine needle and the use thereof
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012304A1 Component of bromelain
06/28/2000EP1012296A2 Mammalian thioredoxin
06/28/2000EP1012284A1 Mpl ligand analogs
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012270A2 Kay - a novel immune system protein
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012263A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012260A1 Interleukin-20
06/28/2000EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex
06/28/2000EP1012189A1 Treatment of obesity
06/28/2000EP1012172A1 Acylated peptide cytolytic peptide inhibitors
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1012142A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
06/28/2000EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000EP1012139A1 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS
06/28/2000EP1012137A1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists
06/28/2000EP1011734A1 Gene therapy vehicle comprising dermal sheath tissue
06/28/2000EP1011733A1 Compositions and methods for enhancing delivery of therapeutic agents to cells
06/28/2000EP1011726A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011716A4 Neuromedin b receptor antagonists
06/28/2000EP1011716A1 Neuromedin b receptor antagonists
06/28/2000EP1011712A2 Cytokines having neurotrophic activity
06/28/2000EP1011711A1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011708A1 Anti-peptide antibody against human cytochrome p450 3a4
06/28/2000EP1011706A1 METHOD TO PREVENT ACCELERATED ATHEROSCLEROSIS USING (sRAGE) SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS
06/28/2000EP1011694A2 Conditioning for allogeneic stem cell transplantation
06/28/2000EP1011686A1 Modulation of human mast cell activation
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011675A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 1564